Noncanonical Roles of G Protein-coupled Receptor Kinases in Cardiovascular Signaling

Journal of Cardiovascular Pharmacology

Volumn 70, Issue 3, 2017, Pages 129-141

  Schumacher, Sarah M ^a   Koch, Walter J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiovascular; GPCR; GRK

Indexed keywords

G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 3; G PROTEIN COUPLED RECEPTOR KINASE 5; ADRBK1 PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR KINASE; GRK5 PROTEIN, HUMAN;

CARDIOVASCULAR FUNCTION; CELL SURVIVAL; ENZYME PHOSPHORYLATION; HEART DEVELOPMENT; HEART FAILURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MITOCHONDRIAL BIOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CARDIOVASCULAR DISEASE; ENZYMOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; G-PROTEIN-COUPLED RECEPTOR KINASE 2; G-PROTEIN-COUPLED RECEPTOR KINASE 5; G-PROTEIN-COUPLED RECEPTOR KINASES; HUMANS; SIGNAL TRANSDUCTION;

EID: 85015893073     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000483     Document Type: Review

References (167)

1. Lefkowitz RJ. Seven transmembrane receptors: something old, something new. Acta Physiol (Oxf). 2007;190:9-19.
2. Katritch V, Cherezov V, Stevens RC. Structure-function of the G protein-coupled receptor superfamily. Annu Rev Pharmacol Toxicol. 2013;53:531-556.
3. Inglese J, Freedman NJ, Koch WJ, et al. Structure and mechanism of the G protein-coupled receptor kinases. J Biol Chem. 1993;268:23735-23738.
4. Penn RB, Pronin AN, Benovic JL. Regulation of G protein-coupled receptor kinases. Trends Cardiovasc Med. 2000;10:81-89.
5. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002;3:639-650.
6. Pitcher JA, Freedman NJ, Lefkowitz RJ. G protein-coupled receptor kinases. Annu Rev Biochem. 1998;67:653-692.
7. DeWire SM, Ahn S, Lefkowitz RJ, et al. Beta-arrestins and cell signaling. Annu Rev Physiol. 2007;69:483-510.
8. Rajagopal S, Rajagopal K, Lefkowitz RJ. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov. 2010;9:373-386.
9. Zidar DA, Violin JD, Whalen EJ, et al. Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands. Proc Natl Acad Sci USA. 2009;106:9649-9654.
10. Pearce LR, Komander D, Alessi DR. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol. 2010;11:9-22.
11. Sato PY, Chuprun JK, Schwartz M, et al. The evolving impact of g protein-coupled receptor kinases in cardiac health and disease. Physiol Rev. 2015;95:377-404.
12. Premont RT, Gainetdinov RR. Physiological roles of G proteincoupled receptor kinases and arrestins. Annu Rev Physiol. 2007;69: 511-534.
13. Gainetdinov RR, Bohn LM, Walker JK, et al. Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron. 1999;24:1029-1036.
14. Drake MT, Shenoy SK, Lefkowitz RJ. Trafficking of G protein-coupled receptors. Circ Res. 2006;99:570-582.
15. Yang J, Villar VA, Armando I, et al. G protein-coupled receptor kinases: crucial regulators of blood pressure. J Am Heart Assoc. 2016;5. doi: 10.1161/JAHA.116.003519.e003519. pii: e003519.
16. Homan KT, Tesmer JJ. Structural insights into G protein-coupled receptor kinase function. Curr Opin Cell Biol. 2014;27:25-31.
17. Huang ZM, Gold JI, Koch WJ. G protein-coupled receptor kinases in normal and failing myocardium. Front Biosci (Landmark Ed). 2011;16: 3047-3060.
18. Hisatomi O, Matsuda S, Satoh T, et al. A novel subtype of G-proteincoupled receptor kinase, GRK7, in teleost cone photoreceptors. FEBS Lett. 1998;424:159-164.
19. Inglese J, Koch WJ, Caron MG, et al. Isoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases. Nature. 1992;359:147-150.
20. Jiang X, Benovic JL, Wedegaertner PB. Plasma membrane and nuclear localization of G protein coupled receptor kinase 6A. Mol Biol Cell. 2007;18:2960-2969.
21. Premont RT, Macrae AD, Stoffel RH, et al. Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J Biol Chem. 1996;271:6403-6410.
22. Stoffel RH, Randall RR, Premont RT, et al. Palmitoylation of G proteincoupled receptor kinase, GRK6. Lipid modification diversity in the GRK family. J Biol Chem. 1994;269:27791-27794.
23. Thiyagarajan MM, Stracquatanio RP, Pronin AN, et al. A predicted amphipathic helix mediates plasma membrane localization of GRK5. J Biol Chem. 2004;279:17989-17995.
24. Gurevich EV, Tesmer JJ, Mushegian A, et al. G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther. 2012;133:40-69.
25. Mumby SM, Casey PJ, Gilman AG, et al. G protein gamma subunits contain a 20-carbon isoprenoid. Proc Natl Acad Sci USA. 1990;87: 5873-5877.
26. Koch WJ, Inglese J, Stone WC, et al. The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase. J Biol Chem. 1993;268:8256-8260.
27. Pitcher JA, Inglese J, Higgins JB, et al. Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. Science. 1992;257:1264-1267.
28. Touhara K, Koch WJ, Hawes BE, et al. Mutational analysis of the pleckstrin homology domain of the beta-adrenergic receptor kinase. Differential effects on G beta gamma and phosphatidylinositol 4,5-bisphosphate binding. J Biol Chem. 1995;270:17000-17005.
29. DebBurman SK, Ptasienski J, Benovic JL, et al. G protein-coupled receptor kinase GRK2 is a phospholipid-dependent enzyme that can be conditionally activated by G protein betagamma subunits. J Biol Chem. 1996;271:22552-22562.
30. Yang P, Homan KT, Li Y, et al. Effect of lipid composition on the membrane orientation of the G protein-coupled receptor kinase 2-Gbeta1gamma2 complex. Biochemistry. 2016;55:2841-2848.
31. Clapham DE, Neer EJ. G protein beta gamma subunits. Annu Rev Pharmacol Toxicol. 1997;37:167-203.
32. Dupre DJ, Robitaille M, Rebois RV, et al. The role of Gbetagamma subunits in the organization, assembly, and function of GPCR signaling complexes. Annu Rev Pharmacol Toxicol. 2009;49:31-56.
33. Khan SM, Sleno R, Gora S, et al. The expanding roles of Gbetagamma subunits in G protein-coupled receptor signaling and drug action. Pharmacol Rev. 2013;65:545-577.
34. Huang CC, Tesmer JJ. Recognition in the face of diversity: interactions of heterotrimeric G proteins and G protein-coupled receptor (GPCR) kinases with activated GPCRs. J Biol Chem. 2011;286: 7715-7721.
35. Pierce KL, Lefkowitz RJ. Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat Rev Neurosci. 2001; 2:727-733.
36. Dorn GW II. GRK mythology: G-protein receptor kinases in cardiovascular disease. J Mol Med (Berl). 2009;87:455-463.
37. Ungerer M, Bohm M, Elce JS, et al. Altered expression of betaadrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 1993;87:454-463.
38. Cho MC, Rapacciuolo A, Koch WJ, et al. Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression. J Biol Chem. 1999;274:22251-22256.
39. Maurice JP, Shah AS, Kypson AP, et al. Molecular beta-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol. 1999;276(6 pt 2):H1853-H1860.
40. Ping P, Anzai T, Gao M, et al. Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. Am J Physiol. 1997;273(2 pt 2):H707-H717.
41. Yi XP, Gerdes AM, Li F. Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart-failure-prone rats. Hypertension. 2002;39:1058-1063.
42. Hullmann J, Traynham CJ, Coleman RC, et al. The expanding GRK interactome: implications in cardiovascular disease and potential for therapeutic development. Pharmacol Res. 2016;110:52-64.
43. Penela P, Murga C, Ribas C, et al. The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol. 2010;160:821-832.
44. Sterne-Marr R, Dhami GK, Tesmer JJ, et al. Characterization of GRK2 RH domain-dependent regulation of GPCR coupling to heterotrimeric G proteins. Methods Enzymol. 2004;390:310-336.
45. Pao CS, Benovic JL. Phosphorylation-independent desensitization of G protein-coupled receptors? Sci STKE. 2002;2002:pe42.
46. Willets JM, Nahorski SR, Challiss RA. Roles of phosphorylationdependent and-independent mechanisms in the regulation of M1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 in hippocampal neurons. J Biol Chem. 2005;280:18950-18958.
47. Dhami GK, Anborgh PH, Dale LB, et al. Phosphorylation-independent regulation of metabotropic glutamate receptor signaling by G proteincoupled receptor kinase 2. J Biol Chem. 2002;277:25266-25272.
48. Penela P, Murga C, Ribas C, et al. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. Cardiovasc Res. 2006;69:46-56.
49. Lafarga V, Mayor F Jr, Penela P. The interplay between G proteincoupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility. Cell Adh Migr. 2012;6:495-501.
50. Penela P, Nogues L, Mayor F Jr. Role of G protein-coupled receptor kinases in cell migration. Curr Opin Cell Biol. 2014;27:10-17.
51. Garcia-Guerra L, Nieto-Vazquez I, Vila-Bedmar R, et al. G proteincoupled receptor kinase 2 plays a relevant role in insulin resistance and obesity. Diabetes. 2010;59:2407-2417.
52. Usui I, Imamura T, Babendure JL, et al. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol Endocrinol. 2005;19:2760-2768.
53. Mayor F Jr, Lucas E, Jurado-Pueyo M, et al. G Protein-coupled receptor kinase 2 (GRK2): a novel modulator of insulin resistance. Arch Physiol Biochem. 2011;117:125-130.
54. Woodall MC, Ciccarelli M, Woodall BP, et al. G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism. Circ Res. 2014;114:1661-1670.
55. Penela P, Ribas C, Mayor F Jr. Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell Signal. 2003;15:973-981.
56. Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature. 2003;426:574-579.
57. Jimenez-Sainz MC, Murga C, Kavelaars A, et al. G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from G protein subunits. Mol Biol Cell. 2006;17:25-31.
58. Liu S, Premont RT, Kontos CD, et al. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med. 2005;11:952-958.
59. Ribas C, Penela P, Murga C, et al. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta. 2007;1768:913-922.
60. Premont RT, Claing A, Vitale N, et al. beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc Natl Acad Sci USA. 1998;95:14082-14087.
61. Naga Prasad SV, Barak LS, Rapacciuolo A, et al. Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by betaadrenergic receptor kinase 1. A role in receptor sequestration. J Biol Chem. 2001;276:18953-18959.
62. Carman CV, Lisanti MP, Benovic JL. Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem. 1999;274:8858-8864.
63. Pronin AN, Satpaev DK, Slepak VZ, et al. Regulation of G proteincoupled receptor kinases by calmodulin and localization of the calmodulin binding domain. J Biol Chem. 1997;272:18273-18280.
64. Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev. 2001;53:1-24.
65. Rybin VO, Xu X, Lisanti MP, et al. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem. 2000;275:41447-41457.
66. Steinberg SF. The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. Circ Res. 1999;85:1101-1111.
67. Cohen AW, Park DS, Woodman SE, et al. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol. 2003;284: C457-C474.
68. Park DS, Woodman SE, Schubert W, et al. Caveolin-1/3 doubleknockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol. 2002;160:2207-2217.
69. Pitcher JA, Tesmer JJ, Freeman JL, et al. Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases. J Biol Chem. 1999;274:34531-34534.
70. Carman CV, Parent JL, Day PW, et al. Selective regulation of Galpha (q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2. J Biol Chem. 1999;274:34483-34492.
71. Sallese M, Mariggio S, D'Urbano E, et al. Selective regulation of Gq signaling by G protein-coupled receptor kinase 2: direct interaction of kinase N terminus with activated galphaq. Mol Pharmacol. 2000;57: 826-831.
72. Sterne-Marr R, Tesmer JJ, Day PW, et al. G protein-coupled receptor Kinase 2/G alpha q/11 interaction. A novel surface on a regulator of G protein signaling homology domain for binding G alpha subunits. J Biol Chem. 2003;278:6050-6058.
73. Usui H, Nishiyama M, Moroi K, et al. RGS domain in the aminoterminus of G protein-coupled receptor kinase 2 inhibits Gq-mediated signaling. Int J Mol Med. 2000;5:335-340.
74. D'Angelo DD, Sakata Y, Lorenz JN, et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA. 1997;94:8121-8126.
75. Dorn GW II, Tepe NM, Lorenz JN, et al. Low-and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice. Proc Natl Acad Sci USA. 1999;96:6400-6405.
76. Adams JW, Sakata Y, Davis MG, et al. Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA. 1998;95:10140-10145.
77. Rogers JH, Tsirka A, Kovacs A, et al. RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice. J Mol Cell Cardiol. 2001;33:209-218.
78. Akhter SA, Luttrell LM, Rockman HA, et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 1998;280:574-577.
79. Esposito G, Prasad SV, Rapacciuolo A, et al. Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation. 2001;103:1453-1458.
80. Esposito G, Rapacciuolo A, Naga Prasad SV, et al. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation. 2002;105:85-92.
81. Tesmer VM, Kawano T, Shankaranarayanan A, et al. Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Science. 2005;310:1686-1690.
82. Day PW, Tesmer JJ, Sterne-Marr R, et al. Characterization of the GRK2 binding site of Galphaq. J Biol Chem. 2004;279:53643-53652.
83. Schumacher SM, Gao E, Cohen M, et al. A peptide of the RGS domain of GRK2 binds and inhibits Galpha(q) to suppress pathological cardiac hypertrophy and dysfunction. Sci Signal. 2016;9:ra30.
84. Eichmann T, Lorenz K, Hoffmann M, et al. The amino-terminal domain of G-protein-coupled receptor kinase 2 is a regulatory Gbeta gamma binding site. J Biol Chem. 2003;278:8052-8057.
85. Fusco A, Santulli G, Sorriento D, et al. Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis. Cell Signal. 2012; 24:468-475.
86. Obrenovich ME, Palacios HH, Gasimov E, et al. The GRK2 overexpression is a primary hallmark of mitochondrial lesions during early Alzheimer disease. Cardiovasc Psychiatry Neurol. 2009;2009:327360.
87. Brinks H, Boucher M, Gao E, et al. Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via proand anti-apoptotic mechanisms. Circ Res. 2010;107:1140-1149.
88. Fan Q, Chen M, Zuo L, et al. Myocardial Ablation of G protein-coupled receptor kinase 2 (GRK2) decreases ischemia/reperfusion injury through an anti-intrinsic apoptotic pathway. PLoS One. 2013;8:e66234.
89. Chen M, Sato PY, Chuprun JK, et al. Prodeath signaling of G proteincoupled receptor kinase 2 in cardiac myocytes after ischemic stress occurs via extracellular signal-regulated kinase-dependent heat shock protein 90-mediated mitochondrial targeting. Circ Res. 2013;112: 1121-1134.
90. Luo J, Benovic JL. G protein-coupled receptor kinase interaction with Hsp90 mediates kinase maturation. J Biol Chem. 2003;278:50908-50914.
91. Sato PY, Chuprun JK, Ibetti J, et al. GRK2 compromises cardiomyocyte mitochondrial function by diminishing fatty acid-mediated oxygen consumption and increasing superoxide levels. J Mol Cell Cardiol. 2015;89 (pt B):360-364.
92. Penela P, Elorza A, Sarnago S, et al. Beta-arrestin-and c-Src-dependent degradation of G-protein-coupled receptor kinase 2. EMBO J. 2001;20: 5129-5138.
93. Sarnago S, Elorza A, Mayor F Jr. Agonist-dependent phosphorylation of the G protein-coupled receptor kinase 2 (GRK2) by Src tyrosine kinase. J Biol Chem. 1999;274:34411-34416.
94. Mariggio S, Garcia-Hoz C, Sarnago S, et al. Tyrosine phosphorylation of G-protein-coupled-receptor kinase 2 (GRK2) by c-Src modulates its interaction with Galphaq. Cell Signal. 2006;18:2004-2012.
95. Elorza A, Sarnago S, Mayor F Jr. Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases. Mol Pharmacol. 2000;57:778-783.
96. Whalen EJ, Foster MW, Matsumoto A, et al. Regulation of betaadrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell. 2007;129:511-522.
97. Huang ZM, Gao E, Fonseca FV, et al. Convergence of G proteincoupled receptor and S-nitrosylation signaling determines the outcome to cardiac ischemic injury. Sci Signal. 2013;6:ra95.
98. Avendano MS, Lucas E, Jurado-Pueyo M, et al. Increased nitric oxide bioavailability in adult GRK2 hemizygous mice protects against angiotensin II-induced hypertension. Hypertension. 2014;63:369-375.
99. Guccione M, Ettari R, Taliani S, et al. G-protein-coupled receptor kinase 2 (GRK2) inhibitors: current trends and future perspectives. J Med Chem. 2016;59:9277-9294.
100. Thal DM, Homan KT, Chen J, et al. Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractility. ACS Chem Biol. 2012;7:1830-1839.
101. Schumacher SM, Gao E, Zhu W, et al. Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction. Sci Transl Med. 2015;7:277ra31.
102. Homan KT, Wu E, Wilson MW, et al. Structural and functional analysis of g protein-coupled receptor kinase inhibition by paroxetine and a rationally designed analog. Mol Pharmacol. 2014;85:237-248.
103. Waldschmidt HV, Homan KT, Cruz-Rodriguez O, et al. Structure-based design, synthesis, and biological evaluation of highly selective and potent G protein-coupled receptor kinase 2 inhibitors. J Med Chem. 2016;59:3793-3807.
104. Benovic JL, Onorato JJ, Arriza JL, et al. Cloning, expression, and chromosomal localization of beta-adrenergic receptor kinase 2. A new member of the receptor kinase family. J Biol Chem. 1991;266:14939-14946.
105. Vinge LE, Oie E, Andersson Y, et al. Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats. Am J Physiol Heart Circ Physiol. 2001;281:H2490-H2499.
106. Koch WJ, Rockman HA, Samama P, et al. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science. 1995;268:1350-1353.
107. Rockman HA, Choi DJ, Rahman NU, et al. Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc Natl Acad Sci USA. 1996;93:9954-9959.
108. Iaccarino G, Rockman HA, Shotwell KF, et al. Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. Am J Physiol. 1998;275(4 pt 2):H1298-H1306.
109. Walker JK, Peppel K, Lefkowitz RJ, et al. Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. Am J Physiol. 1999;276(4 pt 2):R1214-R1221.
110. Vinge LE, Andressen KW, Attramadal T, et al. Substrate specificities of g protein-coupled receptor kinase-2 and-3 at cardiac myocyte receptors provide basis for distinct roles in regulation of myocardial function. Mol Pharmacol. 2007;72:582-591.
111. Alcantara-Hernandez R, Casas-Gonzalez P, Garcia-Sainz JA. Roles of c-Src in alpha1B-adrenoceptor phosphorylation and desensitization. Auton Autacoid Pharmacol. 2008;28:29-39.
112. Chuang TT, Pompili E, Paolucci L, et al. Identification of a short sequence highly divergent between beta-adrenergic-receptor kinases 1 and 2 that determines the affinity of binding to betagamma subunits of heterotrimeric guanine-nucleotide-binding regulatory proteins. Eur J Biochem. 1997;245:533-540.
113. Daaka Y, Pitcher JA, Richardson M, et al. Receptor and G betagamma isoform-specific interactions with G protein-coupled receptor kinases. Proc Natl Acad Sci USA. 1997;94:2180-2185.
114. Kleuss C, Scherubl H, Hescheler J, et al. Different beta-subunits determine G-protein interaction with transmembrane receptors. Nature. 1992;358:424-426.
115. Kleuss C, Scherubl H, Hescheler J, et al. Selectivity in signal transduction determined by gamma subunits of heterotrimeric G proteins. Science. 1993;259:832-834.
116. Vinge LE, von Lueder TG, Aasum E, et al. Cardiac-restricted expression of the carboxyl-terminal fragment of GRK3 uncovers distinct functions of GRK3 in regulation of cardiac contractility and growth: GRK3 controls cardiac alpha1-adrenergic receptor responsiveness. J Biol Chem. 2008;283:10601-10610.
117. Lin F, Owens WA, Chen S, et al. Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ Res. 2001;89:343-350.
118. Du XJ, Fang L, Gao XM, et al. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction. J Mol Cell Cardiol. 2004;37:979-987.
119. Du XJ, Gao XM, Kiriazis H, et al. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival. Cardiovasc Res. 2006;71:735-743.
120. von Lueder TG, Gravning J, How OJ, et al. Cardiomyocyte-restricted inhibition of G protein-coupled receptor kinase-3 attenuates cardiac dysfunction after chronic pressure overload. Am J Physiol Heart Circ Physiol. 2012;303:H66-H74.
121. Barnes PJ. Muscarinic receptors in airways: recent developments. J Appl Physiol (1985). 1990;68:1777-1785.
122. Cabezas GA, Graf PD, Nadel JA. Sympathetic versus parasympathetic nervous regulation of airways in dogs. J Appl Physiol (1985). 1971;31: 651-655.
123. Garssen J, Van Loveren H, Gierveld CM, et al. Functional characterization of muscarinic receptors in murine airways. Br J Pharmacol. 1993;109:53-60.
124. Desai KH, Sato R, Schauble E, et al. Cardiovascular indexes in the mouse at rest and with exercise: new tools to study models of cardiac disease. Am J Physiol. 1997;272(2 pt 2):H1053-H1061.
125. Head GA. Central monoamine neurons and cardiovascular control. Kidney Int Suppl. 1992;37:S8-S13.
126. Arnett DK, Devereux RB, Kitzman D, et al; Hypertension Genetic Epidemiology Network Study Group. Linkage of left ventricular contractility to chromosome 11 in humans: the HyperGEN Study. Hypertension. 2001;38:767-772.
127. Premont RT, Koch WJ, Inglese J, et al. Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases. J Biol Chem. 1994;269:6832-6841.
128. Kunapuli P, Benovic JL. Cloning and expression of GRK5: a member of the G protein-coupled receptor kinase family. Proc Natl Acad Sci USA. 1993;90:5588-5592.
129. Burkhalter MD, Fralish GB, Premont RT, et al. Grk5l controls heart development by limiting mTOR signaling during symmetry breaking. Cell Rep. 2013;4:625-632.
130. Philipp M, Berger IM, Just S, et al. Overlapping and opposing functions of G protein-coupled receptor kinase 2 (GRK2) and GRK5 during heart development. J Biol Chem. 2014;289:26119-26130.
131. Yi XP, Zhou J, Baker J, et al. Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure. Anat Rec A Discov Mol Cell Evol Biol. 2005;282:13-23.
132. Dzimiri N, Muiya P, Andres E, et al. Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases. Eur J Pharmacol. 2004;489:167-177.
133. Monto F, Oliver E, Vicente D, et al. Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure etiology and correlates to clinical variables. Am J Physiol Heart Circ Physiol. 2012;303:H368-H376.
134. Aguero J, Almenar L, Monto F, et al. Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure. J Card Fail. 2012;18:53-61.
135. Pronin AN, Benovic JL. Regulation of the G protein-coupled receptor kinase GRK5 by protein kinase C. J Biol Chem. 1997;272:3806-3812.
136. Traynham CJ, Hullmann J, Koch WJ. Canonical and non-canonical actions of GRK5 in the heart. J Mol Cell Cardiol. 2016;92:196-202.
137. Martini JS, Raake P, Vinge LE, et al. Uncovering G proteincoupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc Natl Acad Sci USA. 2008;105: 12457-12462.
138. Johnson LR, Robinson JD, Lester KN, et al. Distinct structural features of G protein-coupled receptor kinase 5 (GRK5) regulate its nuclear localization and DNA-binding ability. PLoS One. 2013;8:e62508.
139. Johnson LR, Scott MG, Pitcher JA. G protein-coupled receptor kinase 5 contains a DNA-binding nuclear localization sequence. Mol Cell Biol. 2004;24:10169-10179.
140. Gold JI, Martini JS, Hullmann J, et al. Nuclear translocation of cardiac G protein-coupled receptor kinase 5 downstream of select Gq-activating hypertrophic ligands is a calmodulin-dependent process. PLoS One. 2013;8:e57324.
141. Zhang Y, Matkovich SJ, Duan X, et al. Nuclear effects of G-protein receptor kinase 5 on histone deacetylase 5-regulated gene transcription in heart failure. Circ Heart Fail. 2011;4:659-668.
142. Pronin AN, Morris AJ, Surguchov A, et al. Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J Biol Chem. 2000; 275:26515-26522.
143. Gold JI, Gao E, Shang X, et al. Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication. Circ Res. 2012;111:1048-1053.
144. Hullmann JE, Grisanti LA, Makarewich CA, et al. GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity. Circ Res. 2014;115:976-985.
145. Liu P, Wang X, Gao N, et al. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression. Brain Res. 2010;1307:134-141.
146. Valanne S, Myllymaki H, Kallio J, et al. Genome-wide RNA interference in Drosophila cells identifies G protein-coupled receptor kinase 2 as a conserved regulator of NF-kappaB signaling. J Immunol. 2010;184: 6188-6198.
147. Islam KN, Bae JW, Gao E, et al. Regulation of nuclear factor kappaB (NF-kappaB) in the nucleus of cardiomyocytes by G protein-coupled receptor kinase 5 (GRK5). J Biol Chem. 2013; 288:35683-35689.
148. Patial S, Shahi S, Saini Y, et al. G-protein coupled receptor kinase 5 mediates lipopolysaccharide-induced NFkappaB activation in primary macrophages and modulates inflammation in vivo in mice. J Cell Physiol. 2011;226:1323-1333.
149. Parameswaran N, Pao CS, Leonhard KS, et al. Arrestin-2 and G proteincoupled receptor kinase 5 interact with NFkappaB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages. J Biol Chem. 2006;281:34159-34170.
150. Sorriento D, Ciccarelli M, Santulli G, et al. The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. Proc Natl Acad Sci USA. 2008; 105:17818-17823.
151. Nobles KN, Xiao K, Ahn S, et al. Distinct phosphorylation sites on the beta(2)-adrenergic receptor establish a barcode that encodes differential functions of beta-arrestin. Sci Signal. 2011;4:ra51.
152. Rakesh K, Yoo B, Kim IM, et al. beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress. Sci Signal. 2010;3: ra46.
153. Noma T, Lemaire A, Naga Prasad SV, et al. Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest. 2007;117:2445-2458.
154. Homan KT, Waldschmidt HV, Glukhova A, et al. Crystal structure of G protein-coupled receptor kinase 5 in complex with a rationally designed inhibitor. J Biol Chem. 2015;290:20649-20659.
155. Penela P, Ribas C, Aymerich I, et al. G protein-coupled receptor kinase 2 positively regulates epithelial cell migration. EMBO J. 2008;27:1206-1218.
156. Ciccarelli M, Chuprun JK, Rengo G, et al. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation. 2011;123:1953-1962.
157. Cipolletta E, Campanile A, Santulli G, et al. The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptorinduced insulin resistance. Cardiovasc Res. 2009;84:407-415.
158. Usui I, Imamura T, Satoh H, et al. GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. EMBO J. 2004;23:2821-2829.
159. Iaccarino G, Tomhave ED, Lefkowitz RJ, et al. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. Circulation. 1998;98:1783-1789.
160. De Blasi A, Parruti G, Sallese M. Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of beta-adrenergic receptor kinase 1 and 2. J Clin Invest. 1995;95:203-210.
161. Ramos-Ruiz R, Penela P, Penn RB, et al. Analysis of the human G protein-coupled receptor kinase 2 (GRK2) gene promoter: regulation by signal transduction systems in aortic smooth muscle cells. Circulation. 2000;101:2083-2089.
162. Condorelli G, Latronico MV, Dorn GW II. microRNAs in heart disease: putative novel therapeutic targets? Eur Heart J. 2010;31:649-658.
163. Matkovich SJ, Wang W, Tu Y, et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res. 2010;106:166-175.
164. van Rooij E, Sutherland LB, Liu N, et al. A signature pattern of stressresponsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA. 2006;103:18255-18260.
165. Sucharov C, Bristow MR, Port JD. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol. 2008;45:185-192.
166. Hu M, Wang C, Li W, et al. A KSHV microRNA directly targets G protein-coupled receptor kinase 2 to promote the migration and invasion of endothelial cells by inducing CXCR2 and activating AKT signaling. PLoS Pathog. 2015;11:e1005171.
167. Cannavo A, Liccardo D, Eguchi A, et al. Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G proteincoupled receptor kinases. Nat Commun. 2016;7:10877.